Abstract
Background
Organ transplant recipients (OTR) are at marked increased risk of skin cancer and skin infections compared to the general population.
Objectives
The purpose of this study was to acquire long-term incidence data on commonly occurring skin diseases in four different transplant groups.
Materials & Methods
This retrospective single-centre cohort study included 621 OTR. By counting defined malignant, inflammatory, infectious or drug-related skin conditions per patient and visit, incidence rates (IR) for the different groups of OTR were calculated as cases per 1000-patient years and cumulative incidences of non-melanoma skin cancer (NMSC), respectively.
Results
Overall, 2,309 non-malignant skin conditions and 340 NMSC were registered. Skin infections were most common (51.4%), followed by inflammatory skin conditions (35.6%) and sun-induced skin damage (32.9%). Kidney transplant recipients (KTR) had a 4.7-fold (95% CI: 2.7–8.0; p < 0.0001), 2.6-fold (95% CI: 1.2–5.3; p = 0.0098) and 5.4-fold (95% CI: 2.8–10.3; — < 0.0001) higher IR for oral candidiasis, oral aphthosis and herpes simplex virus infections, respectively, compared to the other OTR. Pruritus was most commonly reported in liver transplant recipients (95% CI: 1.3–5.3; p = 0.0047). KTR and lung transplant recipients (LuTR) had a 10.7-fold (95% CI:3.6–43.2; p < 0.0001) higher IR of steroid induced acne. KTR had a 1.6-fold (95% CI: 1.1–2.3; p = 0.0096) higher IR of squamous cell carcinoma compared to the other groups. The incidence of basal cell carcinoma was 2.5-fold higher (95% CI: 1.7–3.6; p < 0.0001) in LuTR, compared to the other OTR.
Conclusion
This study provides additional organ-specific incidence data on non-malignant skin diseases and skin cancer in OTR.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Howard MD, Su JC, Chong AH. Skin cancer following solid organ transplantation: a review of risk factors and models of care. Am J Clin Dermatol 2018; 19: 585–97.
Hofbauer GFL, Bouwes Bavinck JN, Euvrard S. Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 2010; 19: 473–82.
Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61: 715–21.
Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506–9.
Sheil AG. Development of malignancy following renal transplantation in Australia and New Zealand. Transplant Proc 1992; 24: 1275–9.
Ulrich C, Kanitakis J, Stockfleth E, Euvrard S. Skin cancer in organ transplant recipients-where do we stand today? Am J Transplant 2008; 8: 2192–8.
Euvrard S, Kanitakis J, Claudy A. Skin cancer after organ transplantation. N Engl J Med 2003; 348: 1681–91.
Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222–9.
Jensen A, Sværke C, Farkas D, Pedersen L, Kragballe K, Sørensen H. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol 2010; 90: 474–9.
Geusau A, Dunkler D, Messeritsch E, et al. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Int J Dermatol 2008; 47: 918–25.
Rubin RH. Infectious disease complications of renal transplantation. Kidney Int 1993; 44: 221–36.
Dummer JS, Hardy A, Poorsattar A, Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 1983; 36: 259–67.
Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997; 10: 86–124.
Hogewoning AA, Goettsch W, van Loveren H, et al. Skin infections in renal transplant recipients. Clin Transplant 2001; 15: 32–8.
Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515–26.
Gershenwald JE, Scolyer RA. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol 2018; 25: 2105–10.
Christenson LJ, Geusau A, Ferrandiz C, et al. Specialty clinics for the dermatologic care of solid-organ transplant recipients. Dermatol Surg 2004; 30: 598–603.
Wisgerhof HC, Edelbroek JR, de Fijter JW, Feltkamp MC, Willemze R, Bouwes Bavinck JN. Trends of skin diseases in organ-transplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006. Br J Dermatol 2010; 162: 390–6.
Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601–14.
Antoniewicz L, Relijc D, Poitschek C, Presterl E, Geusau A. Mucosal Candida infection and colonisation as well as associated risk factors in solid organ transplant recipients. Eur J Clin Microbiol Infect Dis 2009; 28: 945–57.
López-Pintor RM, Hernández G, de Arriba L, de Andrés A. Comparison of oral lesion prevalence in renal transplant patients under immunosuppressive therapy and healthy controls. Oral Dis 2010; 16: 89–95.
Güleç AT, Demirbilek M, Seçkin D, et al. Superficial fungal infections in 102 renal transplant recipients: a case-control study. J Am Acad Dermatol 2003; 49:187–92.
Spolidorio LC, Spolidorio DM, Massucato EM, Neppelenbroek KH, Campanha NH, Sanches MH. Oral health in renal transplant recipients administered cyclosporin A or tacrolimus. Oral Dis 2006; 12: 309–14.
Parker C. Skin lesions in transplant patients. Dermatol Clin 1990; 8: 313–25.
Manuel O, Kumar D, Singer LG, Cobos I, Humar A. Incidence and clinical characteristics of herpes zoster after lung transplantation. J Heart Lung Transplant 2008; 27: 11–6.
Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis. Transpl Infect Dis 2008; 10: 260–8.
Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004; 4: 108–15.
Kim W, Kim S, Oh J, et al. Incidence and risk factors for herpes zoster after adult liver transplantation. Ann Surg Treat Res 2019; 96: 95–9.
Pergam SA, Forsberg CW, Boeckh MJ, et al. Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients. Transpl Infect Dis 2011; 13: 15–23.
Du-Thanh A, Kluger N, Bensalleh H, Guillot B. Drug-induced acneiform eruption. Am J Clin Dermatol 2011; 12: 233–45.
Yu HJI, Lee SK, Son SJ, Kim YS, Yang HY, Kim JH. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne. Int J Dermatol 1998; 37: 772–7.
Lally A, Casabonne D, Imko-Walczuk B, Newton R, Wojnarowska F. Prevalence of benign cutaneous disease among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol 2011; 25: 462–70.
Savoia P, Cavaliere G, Zavattaro E, Veronese F, Fava P. Inflammatory cutaneous diseases in renal transplant recipients. Int J Mol Sci 2016; 17: 1362.
Wang C, Wang G, Yi H, et al. Symptom experienced three years after liver transplantation under immunosuppression in adults. PLoS One 2013; 18(8): e80584.
Ponziani FR, Bhoori S, Pompili M, et al. Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy. Eur Rev Med Pharmacol Sci 2017; 21: 23–36.
Plana-Pla A, Solé LC, Garcia AB, Valdemoros RL. Mycophenolate mofetil-induced mouth ulcers in a kidney transplant patient: case report and literature review. Nefrologia 2019; 39: 80–3.
Freeman RG. Action spectrum for ultraviolet carcinogenesis. Natl Cancer Inst Monogr 1978; 50: 27–9.
Rashtak S, Dierkhising RA, Kremers WK, Peters SG, Cassivi SD, Otley CC. Incidence and risk factors for skin cancer following lung transplantation. J Am Acad Dermatol 2015; 72: 92–8.
Brewer JD, Colegio OR, Phillips PK, et al. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009; 145: 1391–6.
Mackenzie KA, Wells JE, Lynn KL, et al. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Nephrol Dial Transplant 2010; 25: 300–6.
Jiyad Z, O’Rourke P, Soyer HP, Green AC. Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study. Br JDermatol 2017; 176: 965–70.
Hartmann J, Schüler S, Enk AH, Lonsdorf AS. Skin cancer in organ transplant recipients: dynamics in the incidence and clinical predictors for the first and subsequent post-transplant non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2019; 33: 1281–9.
Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506–9.
Sheil AG. Development of malignancy following renal transplantation in Australia and New Zealand. Transplant Proc 1992; 24: 1275–9.
Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177–86.
Ulrich C, Schmook T, Sachse MM, Sterry W, Stockfleth E. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30: 622–7.
Elnahas S, Olson MT, Kang P, et al. Factors associated with skin cancer in lung transplant recipients: a single-center experience. Clin Transplant 2019; 33: e13718.
Krynitz B, Edgren G, Lindelöf B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008: a Swedish population-based study. Int J Cancer 2013; 132: 1429–38.
Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatology 2017; 153: 296–303.
Gjersvik P, Hansen S, Møller B, et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transpl Int 2000; 13: S380–1.
Tang H, Shi W, Song Y, Han J. Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: a systematic review and meta-analysis. J Am Acad Dermatol 2019; 80: 500–7.
Williams K, Mansh M, Chin-Hong P, Singer J, Arron ST. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients. Clin Infect Dis 2014; 58: 997–1002.
Gräger N, Leffler M, Gottlieb J, et al. Risk factors for developing nonmelanoma skin cancer after lung transplantation. J Skin Cancer 2019; 7089482.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure. Financial support: none. Conflicts of interest: none. Ethical committee: the study was approved by the Ethics Committee of the Medical University of Vienna (Vienna, Austria, EkNr: 1381/2012) in accordance with the Helsinki Declaration.
About this article
Cite this article
Borik-Heil, L., Geroldinger, A., Dunkler, D. et al. The spectrum of skin diseases in four different types of organ-transplant recipients: a comparative single-centre cohort study. Eur J Dermatol 31, 65–74 (2021). https://doi.org/10.1684/ejd.2021.3967
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2021.3967